If a person's cell have the antigen, the antibody should NOT be present in that person's serum. If an antibody to a blood group antigen is present in the serum of a person, his or her cells should lack that antigen. The antigens are on the cells and the antibodies are in the serum.
Therapy-related myeloid leukemia (t-MDS/t-AML) is a well-recognized clinical syndrome occurring as a late complication following cytotoxic therapy.1â5 The term âtherapy-relatedâ leukemia is descriptive and based on a patientâs history of exposure to cytotoxic agents.
AML may be called by other names, including acute myelogenous leukemia, acute. myelocytic leukemia, acute myeloblastic leukemia and acute granulocytic leukemia. About 12,950 new cases of AML were expected to be diagnosed in the United. States in 2011. As of January 2008 an estimated 30,993 people were living with.